Why the study?
Pulmonary hypertension shares the common feature of mitochondrial dysfunction across classifications, but its role in pulmonary vascular remodeling and available therapeutic options warrant comprehensive review.
Design
Review
Authors
Loading...
Mitochondrial dysfunction unifies PH mechanisms; leaves open antioxidant targeting before clinical adoption.
This review highlights the central role of mitochondrial dysfunction in the pathophysiology of pulmonary hypertension and discusses potential mitochondria-targeted therapeutic options.
Ryanto et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: